--- title: "Dulaglutide in India" description: "Dulaglutide in India: weekly GLP-1 RA, CDSCO status, cost vs semaglutide, cardiovascular trial context, and Schedule H prescribing rules.............." canonical: "https://www.kesho.health/keywords/dulaglutide-india" markdown_url: "https://www.kesho.health/md/keywords/dulaglutide-india" language: "en-IN" primary_keyword: "dulaglutide India" --- # Dulaglutide in India — weekly GLP-1 explained > **Short answer:** Dulaglutide is a CDSCO-approved once-weekly GLP-1 receptor agonist in the same drug class as semaglutide and liraglutide—not a separate supplement category. Monthly costs often sit in a similar rupee band to semaglutide depending on dose and sourcing. Physicians choose molecules based on individual response, tolerance, cardiovascular history, and affordability—not social-media brand rankings. **Canonical HTML:** https://www.kesho.health/keywords/dulaglutide-india **Markdown:** https://www.kesho.health/md/keywords/dulaglutide-india ## Weekly GLP-1 option **Check chemist quote** — Compare a pharmacy quote against typical CDSCO-approved GLP-1 ranges — spot grey-market pricing before you pay. [Check chemist quote](https://www.kesho.health/chemist-quote-check) **Monthly budget worksheet** — Plan medicine, labs, consultations, and travel costs for 12–24 months of GLP-1 therapy in India. [Monthly budget worksheet](https://www.kesho.health/glp-1-budget-worksheet) ## What is dulaglutide in the GLP-1 drug class? Dulaglutide is a GLP-1 receptor agonist administered once weekly by subcutaneous injection pen—sharing mechanism with semaglutide and liraglutide but with distinct pharmacokinetics and trial data. CDSCO approves specified diabetes and weight-management indications under physician supervision. It is Schedule H—not over-the-counter—and must be sourced from licensed pharmacies with valid prescriptions matching dispensed inserts. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. Document HbA1c, waist circumference, and weight trends for follow-up visits in metro and tier-2 Indian practice. ## How does weekly dulaglutide dosing work? Patients inject subcutaneously once weekly on a consistent schedule with gradual titration to reduce nausea—similar RSSDI-aligned escalation principles as semaglutide. Rotate abdomen, thigh, and arm sites; use new needles each time. Store unopened pens refrigerated at 2–8°C; follow in-use room temperature limits on labels during Indian summer heat and travel. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. Document HbA1c, waist circumference, and weight trends for follow-up visits in metro and tier-2 Indian practice. ## How do costs compare with semaglutide and tirzepatide? Dulaglutide monthly quotes often fall in a band comparable to semaglutide—roughly ₹8,000–₹18,000 depending on dose, city tier, and generic versus innovator dynamics—while tirzepatide remains premium. Budget consultations, quarterly HbA1c labs, and sharps disposal alongside pen prices. Affordability discussions belong at initiation across twenty-four-month horizons. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. Document HbA1c, waist circumference, and weight trends for follow-up visits in metro and tier-2 Indian practice. ## What cardiovascular trial context informs prescribing? Dulaglutide cardiovascular outcome trial data supports use in established cardiovascular disease alongside diabetes in specialist pathways—individual prescribing integrates RSSDI algorithms with patient comorbidities. It does not replace statins, blood pressure control, or lifestyle fundamentals. Cardiologist and endocrinologist co-management is common in metro Indian practice. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. Document HbA1c, waist circumference, and weight trends for follow-up visits in metro and tier-2 Indian practice. ## Can patients switch between dulaglutide and semaglutide? Physicians may supervise switches between GLP-1 class members when tolerance, affordability, or targets warrant—never overlap doses without orders. Washout or direct-switch protocols vary; carry complete prescription history to consultations. Generic semaglutide expansion may influence switch discussions when costs diverge. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. Document HbA1c, waist circumference, and weight trends for follow-up visits in metro and tier-2 Indian practice. ## What side effects should Indian patients expect? Nausea, bloating, constipation, and occasional diarrhoea peak during titration weeks—manage with smaller meals and hydration during summer heat. Thyroid MTC/MEN2 contraindications and pancreatitis precautions apply as with all GLP-1 receptor agonists. Report severe abdominal pain promptly. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. Document HbA1c, waist circumference, and weight trends for follow-up visits in metro and tier-2 Indian practice. ## How does dulaglutide combine with other diabetes medicines? Metformin and SGLT2 inhibitor pairings occur under RSSDI pathways; sulfonylurea and insulin doses may need hypoglycaemia monitoring. Disclose ayurvedic supplements at every visit. Never add companion agents without physician coordination in elderly polypharmacy patients. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. Document HbA1c, waist circumference, and weight trends for follow-up visits in metro and tier-2 Indian practice. ## What CDSCO verification steps apply before purchase? Match prescription molecule to package insert manufacturer and batch; reject grey-market pens without Schedule H documentation. CDSCO March 2026 advisory intensified unauthorized GLP-1 enforcement—verify quarterly as approved lists expand. Telemedicine prescriptions are valid when clinically appropriate with complete records. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. Document HbA1c, waist circumference, and weight trends for follow-up visits in metro and tier-2 Indian practice. ## Where is broader GLP-1 drug-class context on Kesho? Our GLP-1 explained India guide situates dulaglutide alongside semaglutide, liraglutide, tirzepatide, and oral options with references. This landing captures dulaglutide-specific search intent without brand promotion. Pair with cost and safety guides before pharmacy visits. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. Document HbA1c, waist circumference, and weight trends for follow-up visits in metro and tier-2 Indian practice. ## Quick questions ### Is Dulaglutide in India information on Kesho medical advice? No. Kesho provides drug-class education only. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised treatment decisions. ### Where is the full guide? See our complete medically reviewed guide linked on this page for in-depth coverage with references and India-specific context. ### What is the short answer on dulaglutide in india? Dulaglutide is a CDSCO-approved once-weekly GLP-1 receptor agonist in the same drug class as semaglutide and liraglutide—not a separate supplement category. Monthly costs often sit in a similar rupee band to semaglutide depending on dose and sourcing. Physicians choose molecules based on individual response, tolerance, cardiovascular history, and affordability—not social-media brand rankings. ## Complete guide [glp-1-explained-india](https://www.kesho.health/blog/glp-1-explained-india) · [MD](https://www.kesho.health/md/blog/glp-1-explained-india) ## Related guides - [Semaglutide in India: A Complete Patient Guide](https://www.kesho.health/blog/semaglutide-india-complete-guide) - [Semaglutide vs Tirzepatide: Comparing GLP-1 Class Options](https://www.kesho.health/blog/semaglutide-vs-tirzepatide) - [GLP-1 Cost in India (2026): What Patients Actually Pay](https://www.kesho.health/blog/glp-1-cost-india-2026) --- *Drug-class education only — not medical advice. [Kesho](https://www.kesho.health)*